Utah Medical Products (UTMD)

Utah Medical Products (UTMD) Stock Price & Analysis


UTMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$65.62 - $97.90
Previous Close$68.88
Average Volume (3M)20.19K
Market Cap
Enterprise Value$150.46M
Total Cash (Recent Filing)$92.87M
Total Debt (Recent Filing)$295.00K
Price to Earnings (P/E)15.3
Jul 30, 2024
EPS EstimateN/A
Dividend Yield1.74%
Share Statistics
EPS (TTM)4.51
Shares Outstanding3,528,426
10 Day Avg. Volume14,757
30 Day Avg. Volume20,186
Standard Deviation0.07
Financial Highlights & Ratios
Price to Book (P/B)2.15
Price to Sales (P/S)19.14
Price to Cash Flow (P/CF)11.10
P/FCF Ratio11.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.00
Enterprise Value/Gross Profit5.01
Enterprise Value/Ebitda5.93
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Ownership Overview

10.52% Other Institutional Investors
49.68% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks


What was Utah Medical Products’s price range in the past 12 months?
Utah Medical Products lowest stock price was $65.62 and its highest was $97.90 in the past 12 months.
    What is Utah Medical Products’s market cap?
    Currently, no data Available
    When is Utah Medical Products’s upcoming earnings report date?
    Utah Medical Products’s upcoming earnings report date is Jul 30, 2024 which is in 9 days.
      How were Utah Medical Products’s earnings last quarter?
      Utah Medical Products released its earnings results on Apr 25, 2024. The company reported $1.093 earnings per share for the quarter, beating the consensus estimate of N/A by $1.093.
        Is Utah Medical Products overvalued?
        According to Wall Street analysts Utah Medical Products’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Utah Medical Products pay dividends?
          Utah Medical Products pays a Quarterly dividend of $0.3 which represents an annual dividend yield of 1.74%. See more information on Utah Medical Products dividends here
            What is Utah Medical Products’s EPS estimate?
            Utah Medical Products’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Utah Medical Products have?
            Utah Medical Products has 3,528,426 shares outstanding.
              What happened to Utah Medical Products’s price movement after its last earnings report?
              Utah Medical Products reported an EPS of $1.093 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.301%.
                Which hedge fund is a major shareholder of Utah Medical Products?
                Among the largest hedge funds holding Utah Medical Products’s share is Brandes Investment Partners LP. It holds Utah Medical Products’s shares valued at 5M.

                  Company Description

                  Utah Medical Products

                  Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.
                  Similar Stocks
                  Price & Change
                  Merit Medical Systems
                  Tandem Diabetes Care
                  Varex Imaging
                  Popular Stocks
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis